Centiva Capital’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-13,708
| Closed | -$214K | – | 1678 |
|
|
2024
Q3 | $214K | Buy |
+13,708
| New | +$214K | ﹤0.01% | 1259 |
|
|
2024
Q2 | – | Sell |
-13,141
| Closed | -$205K | – | 1838 |
|
|
2024
Q1 | $205K | Sell |
13,141
-17,331
| -57% | -$271K | 0.01% | 1120 |
|
|
2023
Q4 | $455K | Sell |
30,472
-20,936
| -41% | -$313K | 0.01% | 621 |
|
|
2023
Q3 | $830K | Buy |
+51,408
| New | +$830K | 0.02% | 419 |
|
|
2022
Q3 | – | Sell |
-7,045
| Closed | -$490K | – | 1173 |
|
|
2022
Q2 | $490K | Buy |
+7,045
| New | +$490K | 0.01% | 621 |
|
|
2021
Q3 | – | Sell |
-1,914
| Closed | -$425K | – | 1151 |
|
|
2021
Q2 | $425K | Buy |
+1,914
| New | +$425K | 0.01% | 596 |
|